Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mawson Infrastructure Group Inc. Director's Dealing 2021

Mar 17, 2021

35202_dirs_2021-03-16_ed39637b-604e-46cd-9838-b7c852ad560a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2021-03-09

Reporting Person: Manning James Edward (Director, Chief Executive Officer, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 47971350 Indirect
Common Stock 18333000 Indirect
Common Stock 6111000 Indirect
Common Stock 37582650 Indirect
Common Stock 2444400 Indirect